echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The registration of Artemisia annua pollen prickly liquid medicine has been accepted

    The registration of Artemisia annua pollen prickly liquid medicine has been accepted

    • Last Update: 2022-01-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On December 22, our company issued an announcement stating that it had obtained the "Notice of Acceptance" issued by the National Medical Products Administration a few days ago, and the company's registered "Artemisia annua pollen spotting liquid" application for marketing authorization has been formally accepted


    The drug is indicated for prick test to assist in the diagnosis of type I allergic diseases caused by the sensitization of Artemisia annua/Mugwort pollen


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.